(HealthDay)—Predictors of severe disease have been identified for children with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), according to a study published online Nov. 13 in The Journal of Pediatrics.
Danielle M. Fernandes, M.D., from the Children’s Hospital at Montefiore in Bronx, New York, and colleagues characterized demographic and clinical features of pediatric SARS-CoV-2 syndromes in a multicenter, retrospective, and prospective study. Data were included for 281 pediatric patients hospitalized with acute SARS-CoV-2 infections and multisystem inflammatory syndrome (MIS-C) at eight sites.
Of the pediatric patients, 51, 25, and 25 percent had respiratory disease, MIS-C, and other manifestations, including gastrointestinal illness or fever. The researchers found that compared with patients with respiratory disease, those with MIS-C were more likely to identify as non-Hispanic Black (35 versus 18 percent). Overall, 2 and 41 percent of patients died and were admitted to the intensive care unit, respectively. Predictors of severe respiratory disease in multivariable analyses included obesity and hypoxia on admission (odds ratios, 3.39 and 4.01, respectively). Severe MIS-C was predicted by lower absolute lymphocyte count (odds ratio, 8.33 per-unit decrease in 109 cells/L) and higher C-reactive protein (odds ratio, 1.06 per-unit increase in mg/dL). Disease severity was not predicted by race/ethnicity or socioeconomic status.
“We hope that pediatric providers will use these warning signs to predict which children may need enhanced monitoring and treatment that could prevent them from becoming severely ill or dying,” Fernandes said in a statement.
Follow the latest news on the coronavirus (COVID-19) outbreak
Copyright © 2020 HealthDay. All rights reserved.
Predictors of severe disease ID’d in children with SARS-CoV-2 (2020, November 20)
retrieved 20 November 2020
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.
- COVID case rates hit new high for England, study finds - April 7, 2022
- Govt’s focus on affordable healthcare ensured significant savings for poor, middle class: PM Modi - April 7, 2022
- SRL Diagnostics and Skye Air Mobility collaborate to transport pathology samples using drone logistics - April 6, 2022
- Healthineers sets up new production line of CT scanners in Bengaluru under PLI scheme - April 6, 2022
- Lupin inks licensing pact with Alvion to market drugs in Southeast Asia - April 6, 2022
- Yoga Mahotsav: Ayush Ministry to organise event to demonstrate common yoga on World Health Day - April 6, 2022
- LordsMed forays into the medtech space with launch of health ATMs ‘Lords Sehat’ - April 5, 2022
- ‘Friendly viruses’ can be the next big thing in the history of medical research and more - April 5, 2022
- No setback to Bharat Biotech even as WHO suspends Covaxin UN supply: Sources - April 4, 2022
- Govt panel recommends Serum’s Covovax dose for kids aged 12 and above - April 4, 2022